Takeda related Press Releases
Takeda Announces Establishment of Development Center in China
Takeda Announces Establishment of Development Center in China February 9, 2012Takeda Pharmaceutical Company Limited Takeda Announces Establishment of Development Center in China Osaka, Japan, Read more...
FDA Approves Subcutaneous Administration of VELCADE® In All Approved Indications
FDA Approves Subcutaneous Administration of VELCADE® In All Approved Indications - Study met primary efficacy endpoint of non-inferiority between subcutaneous and intravenous administration - - Read more...
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth OSAKA, Japan, January 18, 2012 - Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced today strategic Read more...
Takeda to Acquire Intellikine, Adding Two Novel Programs to its Oncology Pipeline
Takeda to Acquire Intellikine, Adding Two Novel Programs to its Oncology Pipeline Osaka, Japan, and La Jolla, California, December 20, 2011 - Takeda Pharmaceutical Company Limited (TSE: 4502, Read more...
Takeda to Acquire Intellikine, Adding Two Novel Programs to its Oncology Pipeline
Takeda to Acquire Intellikine, Adding Two Novel Programs to its Oncology Pipeline Osaka, Japan, and La Jolla, California, December 20, 2011 - Takeda Pharmaceutical Company Limited (TSE: 4502, Read more...
Takeda and Affymax Provide Update on Peginesatide Commercialization Rights in Japan
OSAKA, Japan & PALO ALTO, Calif.--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502) and Affymax, Inc. (Nasdaq:AFFY) today announced that Takeda has decided not to commercialize Read more...
Health Canada Approves Feraheme® (ferumoxytol) to Treat Iron Deficiency Anemia in Adults with Chronic Kidney Disease
Health Canada Approves Feraheme® (ferumoxytol) to Treat Iron Deficiency Anemia in Adults with Chronic Kidney Disease ~AMAG Eligible to Receive a $3 Million Milestone Payment from Takeda Related Read more...
Takeda to Launch Global Vaccine Business
Takeda to Launch Global Vaccine Business Company to establish Vaccine Business Division and Appoints Dr. Rajeev Venkayya as its Leader Osaka, Japan, December 5, 2011 - Takeda Pharmaceutical Company Read more...
Affymax and Janssen Biotech Settle Patent Dispute
Ends Ongoing Litigation and Legal Expenses PALO ALTO, Calif.--(BUSINESS WIRE)-- Affymax, Inc. (Nasdaq:AFFY) today announced that it has reached a global settlement agreement with Janssen Biotech, Read more...
Affymax® Reports Third Quarter 2011 Financial Results
PALO ALTO, Calif.--(BUSINESS WIRE)-- Affymax, Inc. (Nasdaq:AFFY) today reported financial results for the third quarter ended September 30, 2011. The net loss for the third quarter of 2011 was $9.8 Read more...
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
